Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,571 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and validation of a comorbidity index for predicting survival outcomes after allogeneic stem cell transplantation in adult patients with acute leukemia: a Korean nationwide cohort study.
Park SS, Kim HJ, Kim TY, Lee JY, Lee JH, Min GJ, Park S, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Kim DW. Park SS, et al. Among authors: kim yj, kim hj, kim dw, kim ty. Blood Res. 2021 Sep 30;56(3):184-196. doi: 10.5045/br.2021.2021107. Blood Res. 2021. PMID: 34462406 Free PMC article.
Differential effects of donor lymphocyte infusion upon treatment response and GVHD according to relapse level and donor sources in patients with myelodysplastic syndrome.
Park S, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Lee S, Kim HJ, Min CK, Lee JW, Kim YJ. Park S, et al. Among authors: kim yj, kim hj, kim ty. Ther Adv Hematol. 2021 Sep 23;12:20406207211043748. doi: 10.1177/20406207211043748. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34589195 Free PMC article.
Hepatic venoocclusive disease/sinusoidal obstruction syndrome with normal portal vein flow mimicking aggravated chronic hepatic GVHD following inotuzumab ozogamicin salvage therapy: a case report of pathologic-radiologic discrepancy.
Lee J, Yoon JH, Kwag D, Lee JH, Kim TY, Min GJ, Park SS, Park S, Lee SE, Cho BS, Eom KS, Kim YJ, Kim HJ, Min CK, Cho SG, Wook Lee J, Hak Lee S, Lee S. Lee J, et al. Among authors: kim yj, kim hj, kim ty. Ther Adv Hematol. 2021 Dec 21;12:20406207211066176. doi: 10.1177/20406207211066176. eCollection 2021. Ther Adv Hematol. 2021. PMID: 34987745 Free PMC article.
A retrospective comparison of salvage intensive chemotherapy versus venetoclax-combined regimen in patients with relapsed/refractory acute myeloid leukemia (AML).
Park S, Kwag D, Kim TY, Lee JH, Lee JY, Min GJ, Park SS, Yahng SA, Jeon YW, Shin SH, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Park S, et al. Among authors: kim yj, kim hj, kim ty. Ther Adv Hematol. 2022 Mar 23;13:20406207221081637. doi: 10.1177/20406207221081637. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35340720 Free PMC article.
Depth of Response to Intensive Chemotherapy Has Significant Prognostic Value among Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Hematopoietic Stem-Cell Transplantation with Intermediate or Adverse Risk at Diagnosis Compared to At-Risk Group According to European Leukemia Net 2017 Risk Stratification.
Kim TY, Park S, Kwag D, Lee JH, Lee J, Min GJ, Park SS, Jeon YW, Shin SH, Yahng SA, Yoon JH, Lee SE, Cho BS, Eom KS, Kim YJ, Lee S, Min CK, Cho SG, Lee JW, Kim HJ. Kim TY, et al. Among authors: kim yj, kim hj. Cancers (Basel). 2022 Jun 29;14(13):3199. doi: 10.3390/cancers14133199. Cancers (Basel). 2022. PMID: 35804971 Free PMC article.
2,571 results